Marketing Claims for Infant Formula: The Need for Evidence

Affiliations

¹ Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Retired former Director of the US Food and Drug Administration's Center for Food Safety and Applied Nutrition.
³ Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Helen K Hughes et al. JAMA Pediatr. 2017.

. 2017 Feb 1;171(2):105-106.

doi: 10.1001/jamapediatrics.2016.3837.

¹ Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Retired former Director of the US Food and Drug Administration's Center for Food Safety and Applied Nutrition.
³ Department of Health Policy and Management, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

No abstract available

Comment in

Marketing Claims for Infant Formula Additives and Infant Formula.
Kent G. Kent G. JAMA Pediatr. 2017 Aug 1;171(8):811. doi: 10.1001/jamapediatrics.2017.1592. JAMA Pediatr. 2017. PMID: 28628703 No abstract available.
Marketing Claims for Infant Formula Additives and Infant Formula-Reply.
Hughes HK, Landa MM, Sharfstein JM. Hughes HK, et al. JAMA Pediatr. 2017 Aug 1;171(8):811-812. doi: 10.1001/jamapediatrics.2017.1573. JAMA Pediatr. 2017. PMID: 28628710 No abstract available.